UAE residents will find essential medicines more accessible and affordable following a landmark reform by the Emirates Drug Establishment. Effective February 24, 2026, a new rule mandates multiple authorized agents for each drug, dismantling single-agent monopolies. This move enhances supply chain flexibility, boosts competition, and strengthens the nation’s healthcare sector.
Trending
- IBM’s rout, ‘ghost’ GDP: Why AI doom loop may be just a ‘scary bedtime story’
- Rinku Singh rushes back home due to medical emergency in family
- ‘Bangla-birodhis’: Mamata Banerjee reminds Centre of Bengal proposal after Kerala’s ‘Keralam’ nod
- ‘I am not supportive of that’: Gukesh slams Kramnik over cheating claims
- DNPA Conclave 2026: Navigating technology, inclusion, and future of news in an evolving digital ecosystem
- 4 yrs on, Russia’s Ukraine ‘blitz’ drags on: How the conflict redefined warfare, shattered Europe
- DNPA Conclave 2026 to spotlight economics of digital journalism
- Pollution crackdown: 88 per cent construction sites in Maharashtra receive ‘stop-work’ notice
UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs
By
Add A Comment